We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Albemarle (ALB) Outperforms Broader Market: What You Need to Know
Read MoreHide Full Article
Albemarle (ALB - Free Report) closed the most recent trading day at $148.51, moving +1.23% from the previous trading session. The stock outpaced the S&P 500's daily gain of 0.32%. Meanwhile, the Dow gained 0.6%, and the Nasdaq, a tech-heavy index, added 0.22%.
Coming into today, shares of the specialty chemicals company had gained 17.12% in the past month. In that same time, the Basic Materials sector gained 12.69%, while the S&P 500 gained 4.7%.
Market participants will be closely following the financial results of Albemarle in its upcoming release. On that day, Albemarle is projected to report earnings of -$0.61 per share, which would represent year-over-year growth of 44.04%. Simultaneously, our latest consensus estimate expects the revenue to be $1.36 billion, showing a 10.16% escalation compared to the year-ago quarter.
For the full year, the Zacks Consensus Estimates project earnings of -$1.09 per share and a revenue of $5.08 billion, demonstrating changes of +53.42% and -5.5%, respectively, from the preceding year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Albemarle. These revisions help to show the ever-changing nature of near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 12.12% upward. Albemarle is currently sporting a Zacks Rank of #3 (Hold).
The Chemical - Diversified industry is part of the Basic Materials sector. Currently, this industry holds a Zacks Industry Rank of 210, positioning it in the bottom 15% of all 250+ industries.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Albemarle (ALB) Outperforms Broader Market: What You Need to Know
Albemarle (ALB - Free Report) closed the most recent trading day at $148.51, moving +1.23% from the previous trading session. The stock outpaced the S&P 500's daily gain of 0.32%. Meanwhile, the Dow gained 0.6%, and the Nasdaq, a tech-heavy index, added 0.22%.
Coming into today, shares of the specialty chemicals company had gained 17.12% in the past month. In that same time, the Basic Materials sector gained 12.69%, while the S&P 500 gained 4.7%.
Market participants will be closely following the financial results of Albemarle in its upcoming release. On that day, Albemarle is projected to report earnings of -$0.61 per share, which would represent year-over-year growth of 44.04%. Simultaneously, our latest consensus estimate expects the revenue to be $1.36 billion, showing a 10.16% escalation compared to the year-ago quarter.
For the full year, the Zacks Consensus Estimates project earnings of -$1.09 per share and a revenue of $5.08 billion, demonstrating changes of +53.42% and -5.5%, respectively, from the preceding year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Albemarle. These revisions help to show the ever-changing nature of near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 12.12% upward. Albemarle is currently sporting a Zacks Rank of #3 (Hold).
The Chemical - Diversified industry is part of the Basic Materials sector. Currently, this industry holds a Zacks Industry Rank of 210, positioning it in the bottom 15% of all 250+ industries.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.